Sarah Royalty Tredo

Sarah Royalty Tredo has a wealth of experience in various leadership roles in the pharmaceutical and technology industries. Sarah is currently serving as the Vice President of Commercial Strategy and Growth Initiatives at Emergent BioSolutions. Prior to this, they held the position of Vice President and Divestiture Transition Lead at the same company. Sarah has also been the Vice President and Global Product Development Team Lead, as well as the Global Product Lead for Vaccine Development.

Before joining Emergent BioSolutions, Sarah worked at Takeda for several years. Sarah held the role of Director in various capacities, including Global Commercial, Entyvio, and Global Business Development. Sarah also worked as a Director for Corporate Projects and was responsible for Project Summit.

Prior to their time at Takeda, Sarah worked at TAP Pharmaceuticals as a Senior Product Manager and Product Manager. Sarah also started their career as a Sales Representative at TAP Pharmaceuticals.

Earlier in their career, Sarah worked as a Sales Account Manager at Sun Microsystems.

Overall, Sarah Royalty Tredo has a strong background in strategic leadership and product development in the pharmaceutical and technology industries.

Sarah Royalty Tredo holds a Master of Business Administration (M.B.A.) degree from Northwestern University - Kellogg School of Management, with a focus on Marketing, International Business, and Strategy. Sarah also earned a Bachelor of Science (BS) degree in Marketing and Management from the University of Missouri Trulaske College of Business. In addition to their formal education, Sarah has obtained certifications in "The Six Morning Habits of High Performers" and "Being an Effective Team Member" from LinkedIn. Sarah has also acquired a certification in CMR.